Company intelligence
Cerenome
Think it solvable.
Biotechnology Research
Houston, US
31 employees
Founded 2019
2 public signals
About Cerenome
Cerenome (Nasdaq: CNSY) connects precision diagnostics, targeted therapeutics, and patient data into an integrated central nervous system (CNS) oncology platform designed to improve how CNS cancers are detected, treated, and understood. (Previously Plus Therapeutics)
Verified activity
Signals from Cerenome
2 published signals